Associate Professor Andrew Bersten, Flinders University and Flinders Medical Centre, has made a major contribution to critical care medicine through his work on the treatment of severe cardiogenic pulmonary oedema, where he has demonstrated the benefits of applying continuous positive airway pressure by face mask. As a result, this treatment has been widely adopted. Andrew has also gained international recognition for his research, with Ian Doyle, on acute respiratory distress syndrome, and their world-leading research has significant implications for future treatment of this deadly disease.

Andrew was appointed Professor in the Faculty of Health Sciences at Flinders Univeristy and is the Director of the Intensive and Critical Care Unit at Flinders Medical Centre.

Dr Ian Doyle, Flinder's University, whose early research focused on kidney stone formation, and his discovery of the "crystal matrix protein" has redirected the focus of kidney stone research worldwide. Subsequently, Ian switched to respiratory research, where he has become a leader in his field. Ian's work with Andrew Bersten on acute respiratory distress syndrome has resulted in internationally acclaimed publications. This research has also led to development of a patented test for lung health, with Ian listed officially as "inventor".

Dr Ross McKinnon, University of South Australia, is studying the genetic factors that determine susceptibility to drug and chemical toxicity, research that has important implications for future drug development. He has also developed transgenic models as new tools for understanding the molecular basis of toxicology and chemical carcinogenesis. Ross's work has brought him a high national and international profile in toxicology research, and in addition, his commitment to excellence in teaching has given him a reputation as a fine teacher.

Ross remains at the University of SA as a Professor. In 2007 he became a  member of the AIPS board and continues to assist the Tall Poppy Campaign in South Australia.

Dr Graham (Gus) Nathan, University of Adelaide, is a leading researcher in the fields of turbulence, energy and combustion. His research has an emphasis on reducing greenhouse gas and NO2 emissions from industrial combustion systems. Gus is leader of the chief design team that jointly designed the combustion system for the Olympic Torch and the Olympic Stadium flame. The design required consideration of environmental issues, such as minimising greenhouse gases, and has resulted in a patent of which Gus is a co-inventor.

Gus was promoted to Professor in the School of Mechanical Engineering.

Professor Peter Rathjen, University of Adelaide, has gained an international reputation for his work in molecular genetics and mammalian development. A major focus of Peter's work has been the control of stem cell differentiation. This research has considerable implications for understanding the molecular basis of animal development, and is finding application in the development of new gene and cell therapies for human disease. Patents arising from this work are also being developed, and are expected to be of major commercial and therapeutic value.

In 2006, Peter assumed to role of Dean of the Faculty of Science at the University of Melbourne. He continues to assist the Tall Poppy Campaign in Victoria.

Dr Sarah Robertson, University of Adelaide, is studying the female immune response to semen, and its implications for embryo implantation and placental development. This research is vital for management of implantation failure, a major cause of infertility and miscarriage in humans and a significant constraint in livestock breeding. Sarah's internationally-recognised research on immune problems in early pregnancy is also likely to reduce public health costs, since problems with placental development, which can compromise foetal growth, are associated with disease susceptibility in later life.